Uncategorized
Santen obtains European Commission approval to market Ikervis
Santen Pharmaceutical received approval from the European Commission for a marketing authorization application for Ikervis, according to a press release.Ikervis (cyclosporine) is approved to treat severe keratitis in adults with dry eye disease who have not improved with tear substitute treatment.